Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/16/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Harry W. Wilcox III

Wrong Harry W. Wilcox III?

Chief Operating Officer and Gener...

Flagship Ventures
One Memorial Drive 7Th Floor
Cambridge, Massachusetts 02142
United States

Company Description: Founded in 1999, Flagship Ventures (www.flagshipventures.com) is an entrepreneurship and venture capital firm comprised of a family of funds: OneLiberty Funds, AGTC...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • B.S. , Finance
    University of Arizona
  • M.B.A.
    Boston University
104 Total References
Web References
Harry ...
www.t2bio.com, 30 Sept 2014 [cached]
Harry Wilcox
COO and General Partner, Flagship Ventures
Harry W. Wilcox has served as a member of our board of directors since January 2011. Harry has been Chief Operating Officer and General Partner of Flagship Ventures, a venture capital firm, since 2013. From 2006 to 2013, he was Chief Financial Officer and Partner of Flagship Ventures. From 2004 to 2006, he was Chief Financial Officer and Senior Vice President of Corporate Development of EXACT Sciences. Harry received his M.B.A. from Boston University and his B.S. in Finance from the University of Arizona.
About Us | IV Catheter, IV TherapyTangent Medical
tangentmedical.com, 1 Sept 2014 [cached]
Harry Wilcox Chief Operating Officer and General Partner, Flagship Ventures
Harry Wilcox brings a rich set of experiences and expertise in financial management, operations, fund management and strategy to the Tangent Medical Board of Directors. As COO and General Partner at Flagship Ventures, Harry oversees the firm's financial operations and LP relations/fundraising, and serves as board member or advisor to select portfolio companies. Harry is currently a board member of Black Duck, Celexion, Seahorse Bioscience, Seventh Sense Biosystems and T2 Biosystems.
Harry's career spans 30 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has also served on several Boards of Directors. Most recently he has served as CFO and then Sr. VP Corporate Development for EXACT Sciences (NASDAQ:EXAS), one of Flagship's portfolio companies, and on the Board of another portfolio company, Epitome Biosystems.
In addition to his corporate experience, Harry was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures. Harry has also led an active consulting practice, which included roles as interim CEO of biotech companies Thrasos Therapeutics and Biostratum.
Board of Directors - VisEn
www.visenmedical.com, 22 Mar 2009 [cached]
Harry Wilcox
Mr. Wilcox began working as an advisor to Visen in 2005 and joined the Board in 2007, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. His career spans 28 years and has involved many different roles and functions and public and private companies in the life sciences space, including positions as CFO, Sr. VP BD, and CEO, at EXACT Sciences, Thrasos Therapeutics, and Pyrosequencing. He is currently CFO and Partner at Flagship Ventures. Mr. Wilcox has a deep background in the venture capital community, including tenures with Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures.
Celexion Team
www.celexionbio.com, 7 June 2014 [cached]
Harry Wilcox, Director
Harry is currently Chief Financial Officer and Partner, Flagship Ventures, and brings to Celexion a rich set of experiences and expertise in financial management, operations, fund management and strategy. His career spans 28 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD and CEO. He has also served on several Boards of Directors. In addition to his corporate experience, Harry was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures.
During the last several years Harry has led an active consulting practice which included roles as interim CEO of two biotech companies; Thrasos Therapeutics and Biostrum. Prior to this, Harry was Executive Vice President, Chief of Finance and Corporate Development of Pyrosequencing, a publicly-held biotech company. Earlier, he had been the President and Chief Executive Officer of Cambridge NeuroScience, Inc. until its sale to CeNeS Pharmaceuticals, and before that Sr. VP Business Development and CFO of Cellcor.
As CFO and Partner at Flagship Ventures, Harry manages all financial operations and LP relations/fundraising. He also serves as a member of the investment team and plays a role as board member or advisor to select portfolio companies. Currently Harry also serves as a member of the board at Accuri and Seahorse Biosystems.
Seventh Sense Biosystems :: Company
www.7sbio.com, 21 April 2014 [cached]
Harry Wilcox - Chief Operating Officer and General Partner, Flagship Ventures
Mr. Wilcox joined Flagship Ventures in 2006, bringing a rich set of experiences and expertise in financial management, operations, fund management and strategy. As COO and General Partner at Flagship Ventures, Mr. Wilcox oversees the firm's financial operations and LP relations/fundraising, and serves as board member or advisor to select portfolio companies. Mr. Wilcox is currently a board member of Black Duck, Celexion, Seahorse Bioscience, T2 Biosystems and Tangent Medical.
Mr. Wilcox's career spans 30 years and has involved many different roles and functions including Controller, CFO, Sr. VP BD, and CEO. He has also served on several Boards of Directors. Most recently he has served as CFO and then Sr. VP Corporate Development for EXACT Sciences (NASDAQ:EXAS), one of Flagship's portfolio companies, and on the Board of another portfolio company, Epitome Biosystems.
In addition to his corporate experience, Mr. Wilcox was previously CFO of two venture capital firms, Highland Capital Partners where he was the founding CFO and General Partner, and prior to that, Charles River Ventures. Mr. Wilcox has also led an active consulting practice, which included roles as interim CEO of biotech companies Thrasos Therapeutics and Biostratum. Mr. Wilcox earned a BS in finance from the University of Arizona and an MBA from Boston University School of Management.
Other People with the name "Wilcox":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304